Evaluating the impact of immune checkpoint inhibitors on liver steatosis and function: a retrospective cohort analysis
ICIs did not significantly change liver attenuation or enzyme levels, suggesting they may not exacerbate liver fat deposition or subclinical injury. Further research with additional imaging modalities is warranted.
Authors
- Joanna M. Day
- Douglas Buckner Johnson (ORCID: https://orcid.org/0000-0002-6390-773X)
- Fei Ye (ORCID: https://orcid.org/0000-0001-6472-5076)
- Run Fan
- Sophie Schellhammer
- Virginia Planz
Institutions
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3389/fonc.2025.1683982
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health